Mr. Bush’s Stem Cell Diversion

From Discourse DB
Revision as of 14:17, June 21, 2007 by Yaron Koren (talk | contribs) (New page: {{item |author=The New York Times editorial board |source=The New York Times |date=June 21, 2007 |url=http://www.nytimes.com/2007/06/21/opinion/21thu1.html |quote="Both the Senate and the ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

This is an opinion item.

Author(s) The New York Times editorial board
Source The New York Times
Date June 21, 2007
URL http://www.nytimes.com/2007/06/21/opinion/21thu1.html
Quote
Quotes-start.png "Both the Senate and the House, which passed the embryonic stem cell bill by comfortable but not veto-proof margins, need to summon the strength to override Mr. Bush’s veto, so that important research into possible cures for Parkinson’s, diabetes and other serious ailments can move ahead." Quotes-end.png


Add or change this opinion item's references


This item argues for the position Act should be passed on the topic Stem Cell Research Enhancement Act of 2007.